High Incidence of False-Positive Results in Patients with Acute Infections Other than COVID-19 by the Liaison SARS-CoV-2 Commercial Chemiluminescent Microparticle Immunoassay for Detection of IgG Anti-SARS-CoV-2 Antibodies

Detalles Bibliográficos
Autores principales: Boukli, Narjis, Le Mene, Melchior, Schnuriger, Aurélie, Cuervo, Nancy Stella, Laroche, Cécilia, Morand-Joubert, Laurence, Gozlan, Joël
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2020
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7587123/
https://www.ncbi.nlm.nih.gov/pubmed/32848041
http://dx.doi.org/10.1128/JCM.01352-20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7587123/
https://www.ncbi.nlm.nih.gov/pubmed/32848041
http://dx.doi.org/10.1128/JCM.01352-20

Ejemplares similares